Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in Laboratory MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Reversal of anticoagulation in trauma: a North-American survey on clinical practices among trauma surgeons.J Trauma. 2005; 59: 375-382
- The impact of preinjury antiplatelet and anticoagulant pharmacotherapy on outcomes in elderly patients with hemorrhagic brain injury.Surgery. 2008; 144 ([discussion: 603–5]): 598-603
- A principal component analysis of coagulation after trauma.J Trauma Acute Care Surg. 2013; 74 ([discussion: 1229–30]): 1223-1229
- Earlier detection of coagulopathy with thromboelastometry during pediatric cardiac surgery: a prospective observational study.Paediatr Anaesth. 2013; 23: 222-227
- The International Normalized Ratio overestimates coagulopathy in stable trauma and surgical patients.J Trauma Acute Care Surg. 2013; 75: 947-953
- TEG and ROTEM: technology and clinical applications.Am J Hematol. 2014; 89: 228-232
- Comparison of whole blood fibrin-based clot tests in thrombelastography and thromboelastometry.Anesth Analg. 2012; 114: 721-730
- Sensitivity and specificity of CT scan and angiogram for ongoing internal bleeding following torso trauma.Emerg Med J. 2013; 30: e14
- Falls, older adults, and the trend in utilization of CT in a level I trauma center.AJR Am J Roentgenol. 2012; 198: 985-991
- NICE guidelines for the investigation of head injuries–an anticoagulant loop hole?.Emerg Med J. 2010; 27: 277-278
National Institute for Health and Care Excellence. Head injury clinical guidelines (CG56): triage, assessment, investigation and early management of head injury in infants, children and adults. 2007. Available at: http://www.nice.org.uk/guidance/index.jsp?action=byID&o=11836. Accessed February 10, 2014.
- Traumatic brain injury in anticoagulated patients.J Trauma. 2006; 60: 553-557
- Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range.Chest. 2001; 119: 8S-21S
- Impact of preinjury warfarin and antiplatelet agents on outcomes of trauma patients.Surgery. 2011; 150: 861-868
- Evaluation and management of geriatric trauma: an Eastern Association for the Surgery of Trauma practice management guideline.J Trauma Acute Care Surg. 2012; 73: S345-S350
- Rapid warfarin reversal in anticoagulated patients with traumatic intracranial hemorrhage reduces hemorrhage progression and mortality.J Trauma. 2005; 59 ([discussion: 1137–9]): 1131-1137
- Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, part 2: treatment.Am J Hematol. 2009; 84: 584-588
- Guidelines for the use of fresh frozen plasma. British Committee for Standards in Haematology, Working Party of the Blood Transfusion Task Force.Transfus Med. 1992; 2: 57-63
- Transfusion-related acute lung injury: incidence, pathogenesis and the role of multicomponent apheresis in its prevention.Transfus Med Hemother. 2008; 35: 76-79
- Emergency reversal of anticoagulation and antiplatelet therapies in neurosurgical patients.J Neurosurg. 2010; 112: 307-318
- Rapid warfarin reversal: a 3-factor prothrombin complex concentrate and recombinant factor VIIa cocktail for intracerebral hemorrhage.J Neurosurg. 2012; 116: 491-497
- Oral anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines.Chest. 2012; 141: e44S-e88S
CSL Behring GmbH. Kcentra prescribing information. 2013. Available at: http://www.kcentra.com/prescribing-information.aspx. Accessed February 27, 2014.
- What is the evidence for the off-label use of recombinant factor VIIa (rFVIIa) in the acute reversal of warfarin? ASH evidence-based review 2008.Hematology Am Soc Hematol Educ Program. 2008; : 36-38https://doi.org/10.1182/asheducation-2008.1.36
- Lessons from ximelagatran: issues for future studies evaluating new oral direct thrombin inhibitors for venous thromboembolism prophylaxis in orthopedic surgery.Clin Appl Thromb Hemost. 2009; 15: 316-326
- The challenges of new drugs benefits and risks analysis: lessons from the ximelagatran FDA Cardiovascular Advisory Committee.Contemp Clin Trials. 2006; 27: 432-440
- New anticoagulant agents: direct thrombin inhibitors.Cardiol Clin. 2008; 26 (v–vi): 169-187
- The metabolism and disposition of the oral direct thrombin inhibitor, dabigatran, in humans.Drug Metab Dispos. 2008; 36: 386-399
- In-vitro profile and ex-vivo anticoagulant activity of the direct thrombin inhibitor dabigatran and its orally active prodrug, dabigatran etexilate.Thromb Haemost. 2007; 98: 155-162
- Ecarin chromogenic assay–a new method for quantitative determination of direct thrombin inhibitors like hirudin.Pathophysiol Haemost Thromb. 2003; 33: 184-191
- An evaluation of monitoring possibilities of argatroban using rotational thromboelastometry and activated partial thromboplastin time.Acta Anaesthesiol Scand. 2010; 54: 86-91
- Dabigatran etexilate–a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity.Thromb Haemost. 2010; 103: 1116-1127
Boehringer Ingelheim Pharmaceuticals. Pradaxa prescribing information. 2013. Available at: http://bidocs.boehringer-ingelheim.com/BIWebAccess/ViewServlet.ser?docBase=renetnt&folderPath=/Prescribing%20Information/PIs/Pradaxa/Pradaxa.pdf. Accessed February 27, 2014.
- Managing bleeding in anticoagulated patients with a focus on novel therapeutic agents.J Thromb Haemost. 2009; 7: 107-110
- Neurosurgical complications of direct thrombin inhibitors–catastrophic hemorrhage after mild traumatic brain injury in a patient receiving dabigatran.J Neurosurg. 2012; 116: 1093-1096
- Hemostatic effect of activated factor VII without promotion of thrombus growth in melagatran-anticoagulated primates.Thromb Res. 2007; 119: 121-127
- Recombinant factor VIIa for refractory bleeding after cardiac surgery secondary to anticoagulation with the direct thrombin inhibitor lepirudin.Pharmacotherapy. 2006; 26: 569-577
- Effect of recombinant factor VIIa on melagatran-induced inhibition of thrombin generation and platelet activation in healthy volunteers.Thromb Haemost. 2004; 91: 1090-1096
- Management of dabigatran-associated intracerebral and intraventricular hemorrhage: a case report.J Emerg Med. 2014; 46: 525-529https://doi.org/10.1016/j.jemermed.2013.11.097
- Reversal of dabigatran-induced bleeding with a prothrombin complex concentrate and fresh frozen plasma.Am J Health Syst Pharm. 2012; 69: 1646-1650
- A specific antidote for dabigatran: functional and structural characterization.Blood. 2013; 121: 3554-3562
- Rivaroxaban: a new oral factor Xa inhibitor.Arterioscler Thromb Vasc Biol. 2010; 30: 376-381
- In vitro inhibition of thrombin generation, after tissue factor pathway activation, by the oral, direct factor Xa inhibitor rivaroxaban.J Thromb Haemost. 2007; 5: 886-888
- Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial.Lancet. 2008; 372: 31-39
- Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty.N Engl J Med. 2008; 358: 2765-2775
- Assessment of laboratory assays to measure rivaroxaban–an oral, direct factor Xa inhibitor.Thromb Haemost. 2010; 103: 815-825
- Evaluation of recombinant activated factor VII, prothrombin complex concentrate, and fibrinogen concentrate to reverse apixaban in a rabbit model of bleeding and thrombosis.Int J Cardiol. 2013; 168: 4228-4233
- Reversal of apixaban induced alterations in hemostasis by different coagulation factor concentrates: significance of studies in vitro with circulating human blood.PLoS One. 2013; 8: e78696
- Reversal of rivaroxaban anticoagulation by haemostatic agents in rats and primates.Thromb Haemost. 2013; 110: 162-172
- Parenteral anticoagulants: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines.Chest. 2012; 141: e24S-e43S
- Monitoring of low-molecular-weight heparins in cardiovascular disease.Am J Cardiol. 1998; 82: 33L-36L
- Detection of protamine and heparin after termination of cardiopulmonary bypass by thrombelastometry (ROTEM): results of a pilot study.Anesth Analg. 2009; 108: 743-750
- Neutralization of heparin activity.Handb Exp Pharmacol. 2012; : 265-277
- Recombinant activated factor VII effectively reverses the anticoagulant effects of heparin, enoxaparin, fondaparinux, argatroban, and bivalirudin ex vivo as measured using thromboelastography.Blood Coagul Fibrinolysis. 2007; 18: 547-553
- Towards guidelines for withholding and withdrawal of life prolonging treatment in neonatal medicine.Arch Dis Child Fetal Neonatal Ed. 1994; 70: F66-F70
- Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.N Engl J Med. 2001; 345: 494-502
- Emergency reversal of antiplatelet agents in patients presenting with an intracranial hemorrhage: a clinical review.World Neurosurg. 2010; 74: 279-285
- Effects of antiplatelet agents on outcomes for elderly patients with traumatic intracranial hemorrhage.J Trauma. 2005; 58: 518-522
- Avoidance of bleeding during surgery in patients receiving anticoagulant and/or antiplatelet therapy: pharmacokinetic and pharmacodynamic considerations.Clin Pharmacokinet. 2004; 43: 963-981
- A comparison of platelet function tests and thromboxane metabolites to evaluate aspirin response in healthy individuals and patients with coronary artery disease.Thromb Haemost. 2010; 103: 1245-1253
- A prospective evaluation of platelet function in patients on antiplatelet therapy with traumatic intracranial hemorrhage.J Trauma Acute Care Surg. 2013; 75: 990-994
- The role of ADP receptors in platelet function.Front Biosci. 2006; 11: 1977-1986
- Thromboelastography: potential bedside tool to assess the effects of antiplatelet therapy?.Platelets. 2006; 17: 385-392
- Assessment of platelet inhibition secondary to clopidogrel and aspirin therapy in preoperative acute surgical patients measured by thrombelastography platelet mapping.Br J Anaesth. 2009; 102: 492-498
- Is platelet transfusion efficient to restore platelet reactivity in patients who are responders to aspirin and/or clopidogrel before emergency surgery?.J Trauma Acute Care Surg. 2013; 74: 1367-1369
- Utility of platelet transfusion in adult patients with traumatic intracranial hemorrhage and preinjury antiplatelet use: a systematic review.J Trauma Acute Care Surg. 2012; 72: 1658-1663
Article info
Publication history
Published online: July 19, 2014
Footnotes
The authors have no disclosures or conflicts of interest to declare.
Identification
Copyright
© 2014 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
